Microsoft Word - S_2019_GRC-02_025_S43 Share Acquisition_EN Page 1 – Translation – GRC-02/2019/025 11 December 2019 Subject: Report of the Asset Acquisition To: President The Stock Exchange of
depreciation of plant and machinery that contributed to higher share of cost of goods sold. In addition, the Company executed sales promotional campaigns for slow moving inventories that accounted for lower
came into effect on 31 October 2018, adjusted the par value of both share types to THB 100 per share from THB 1 per share and the rights of U-W1 and U-W4 tradeable warrants to an exercise price of THB 6
expenses as a result of Company’s response plan to COVID-19. EBITDA margin fell to -17.7% (2Q 2019; 22.3%) • Reported net loss of THB 1,213mn, from the EBITDA shortfall as well as higher share of loss from
margin fell to 1.7% (1Q 2019; 9.0%) • Reported net loss of THB 807mn (down 238% YoY), from the aforementioned lower EBITDA as well as higher share of loss from joint ventures and higher depreciation and
ordinary shares with a par value of Baht 1 per share as follows: 1) To capital increase by the General Mandate of Baht 666,332,580.00 from the exceeding 666,332,580.00 newly issued ordinary shares with a par
issuing and allocating not more than 888,443,440.00 new ordinary shares with a par value of Baht 1 per share as follows: 1) To capital increase by the General Mandate of Baht 666,332,580.00 from the
increase of the registered capital of the Company by issuing 650,789,079 newly issued ordinary shares with a par value of Baht 1. 00 per share accounting for 18. 48 percent the Company’ s issued and paid- up
TRIPPLE LIFT SERUM 2. SOS HYALURON X3 CONCENTRATE SERUM 3. SOS HYALURON & COLLAGEN FREEZE-DRIED MASK 4. OXE’CURE ACNE CLEAR POTION 5. OXE'CURE ACNE CLEAR POWDER MUD 6. OXE’CURE ACNE CLEAR POWDER LOTION 7